1.
JAMA
; 328(24): 2394-2395, 2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2312094
RESUMEN
This Viewpoint discusses the controversy surrounding the FDA's efforts to withdraw Makena from the market and the broader implications for the accelerated approval pathway.